- Home
- QBTS vs BLDEW Comparison
QBTS vs BLDEW Comparison
Compare QBTS & BLDEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QBTS
- BLDEW
- Stock Information
- Founded
- QBTS 1999
- BLDEW 2014
- Country
- QBTS Canada
- BLDEW United States
- Employees
- QBTS N/A
- BLDEW 281
- Industry
- QBTS Retail: Computer Software & Peripheral Equipment
- BLDEW Transportation Services
- Sector
- QBTS Technology
- BLDEW Consumer Discretionary
- Exchange
- QBTS Nasdaq
- BLDEW Nasdaq
- Market Cap
- QBTS N/A
- BLDEW N/A
- IPO Year
- QBTS N/A
- BLDEW N/A
- Fundamental
- Price
- QBTS $7.35
- BLDEW $0.21
- Analyst Decision
- QBTS Strong Buy
- BLDEW
- Analyst Count
- QBTS 6
- BLDEW 0
- Target Price
- QBTS $8.42
- BLDEW N/A
- AVG Volume (30 Days)
- QBTS 88.8M
- BLDEW 51.0K
- Earning Date
- QBTS 05-12-2025
- BLDEW 03-13-2025
- Dividend Yield
- QBTS N/A
- BLDEW N/A
- EPS Growth
- QBTS N/A
- BLDEW N/A
- EPS
- QBTS N/A
- BLDEW N/A
- Revenue
- QBTS $8,827,000.00
- BLDEW $241,814,000.00
- Revenue This Year
- QBTS $125.44
- BLDEW N/A
- Revenue Next Year
- QBTS $71.83
- BLDEW N/A
- P/E Ratio
- QBTS N/A
- BLDEW N/A
- Revenue Growth
- QBTS 0.79
- BLDEW 12.04
- 52 Week Low
- QBTS $0.75
- BLDEW $0.30
- 52 Week High
- QBTS $11.95
- BLDEW $0.36
- Technical
- Relative Strength Index (RSI)
- QBTS 48.41
- BLDEW N/A
- Support Level
- QBTS $7.11
- BLDEW N/A
- Resistance Level
- QBTS $8.09
- BLDEW N/A
- Average True Range (ATR)
- QBTS 1.28
- BLDEW 0.00
- MACD
- QBTS -0.22
- BLDEW 0.00
- Stochastic Oscillator
- QBTS 4.86
- BLDEW 0.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.